Figure 3 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies

Puntos clave

• Higher HER2 scores correlate with increased protein expression of cell surface antigens in prostate cancer, enhancing treatment pathways.
• The analysis shows distinct patterns of HER2 expression in prostate cancer versus urothelial cancer, indicating varied responses to therapies.
• Utilizing immunohistochemistry (IHC), the study evaluates protein expression levels in cancerous tissues, providing a basis for therapeutic strategies.
• Further research is needed to establish the efficacy of HER2-targeted therapies across different cancer types, especially in metastatic settings.